Table 4 Differentially spliced genes in somatostatin-positive cells
A | |||||
|---|---|---|---|---|---|
Location of splice event | Gene symbol | Exon Splicing Index | Exon p-val | Exon event name | Exon event score |
Exon 7/8 | DUS4L | − 4.02 | 0.0082 | Alternative 3ʹ acceptor site | 0.2 |
Exon 6/6 | CLIC4 | 5.34 | 0.0015 | Alternative 5ʹ donor site | 0.2 |
3ʹ end of exon 1/1 | RNU5B-6P | − 3.93 | 0.0087 | Alternative 5ʹ donor site | 0.2 |
Exon 11/11 | DBNL; MIR6837 | − 4 | 0.0049 | Alternative 5ʹ donor site | 0.21 |
Exon 7/7 | NDUFS3 | − 4.38 | 5.35E−05 | Alternative 5ʹ donor site | 0.21 |
Exon 6/6 | ARHGDIB | 4.46 | 0.0077 | Alternative 5ʹ donor site | 0.21 |
Exon 20/24 | GTF2IP1 | 4.64 | 9.32E−05 | Alternative 3ʹ acceptor site | 0.21 |
Exon 3/6 | TRIM64C | 5.18 | 0.0089 | Alternative 3ʹ acceptor site | 0.21 |
Intron 4/12 | NFKBIZ | 5.34 | 0.0028 | Alternative 5ʹ donor site | 0.21 |
Exon 1/3 | VAX1 | 9.05 | 0.0038 | Alternative 3ʹ acceptor site | 0.21 |
Intron 8/15 | CARF | − 2.71 | 0.0014 | Intron retention | 0.21 |
Exon 6/6 | HMGN1 | 7.78 | 0.0017 | Alternative 3ʹ acceptor site | 0.21 |
Intron 11/36 | NBPF12 | 2.68 | 0.0023 | Intron retention | 0.21 |
Intron 6/35 | NUP160 | 3.74 | 0.0023 | Intron retention | 0.22 |
Intron 2/9 or Intron 1/8 | AP3M2 | 4.34 | 0.0051 | Intron retention | 0.22 |
Alternative 3ʹ acceptor site | COL28A1 | 4.29 | 0.0068 | Alternative 3ʹ acceptor site | 0.23 |
Intron 12/21 | ACAP1 | 3.01 | 0.0042 | Intron retention | 0.23 |
Exon 3/5 | HINT2 | 2.95 | 0.0004 | Intron retention | 0.24 |
Intron 11/12 | SEPT7P2 | − 3.01 | 0.0089 | Intron retention | 0.24 |
Intron 3/8 or Intron 2/7 | ACTG2 | − 3.09 | 0.005 | Intron retention | 0.24 |
Intron 6 in exon 7/16 | SLC9A8 | 14.06 | 0.0043 | Intron retention | 0.25 |
Intron1 in exon 1/5 | CUTA | 3.34 | 0.0059 | Intron retention | 0.27 |
Intron 14/29 or 30 | TRAPPC11 | − 10.49 | 0.0014 | Intron retention | 0.32 |
Intron 6/8 | STAG3L3; STAG3L2 | 3.78 | 0.0002 | Intron retention | 0.32 |
Intron 3/11 or Intron 2/10 | ACVR2A | 5.65 | 0.0077 | Intron retention | 0.33 |
Intron 5/8 | PRKRIP1 | 4.3 | 0.0019 | Intron retention | 0.36 |
Intron 5/12 or Intron 7/13 or Intron 4/9 | PHYKPL | 20.83 | 0.0014 | Intron retention | 0.36 |
Intron 12/18 or Intron 13/19 | MPP3 | − 4.93 | 0.0013 | Intron retention | 0.37 |
Intron 4/7 | GLT1D1 | − 4.16 | 0.0004 | Intron retention | 0.37 |
B | ||
|---|---|---|
GO biological process complete | Fold enrichment | Raw p value |
Positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400) | > 100 | 0.00 |
Positive regulation of NAD + ADP-ribosyltransferase activity (GO:1901666) | > 100 | 0.01 |
Regulation of NAD + ADP-ribosyltransferase activity (GO:1901664) | > 100 | 0.01 |
Post-embryonic camera-type eye morphogenesis (GO:0048597) | > 100 | 0.01 |
Penile erection (GO:0043084) | > 100 | 0.01 |
Cellular response to redox state (GO:0071461) | > 100 | 0.01 |
Pyrimidine dimer repair by nucleotide-excision repair (GO:0000720) | > 100 | 0.01 |
Sertoli cell proliferation (GO:0060011) | > 100 | 0.01 |
Constitutive secretory pathway (GO:0045054) | > 100 | 0.01 |
Mesenchyme migration (GO:0090131) | > 100 | 0.01 |
tRNA dihydrouridine synthesis (GO:0002943) | > 100 | 0.01 |
Negative regulation of trophoblast cell migration (GO:1901164) | > 100 | 0.01 |
Sperm ejaculation (GO:0042713) | > 100 | 0.01 |
Post-embryonic eye morphogenesis (GO:0048050) | > 100 | 0.01 |
Post-embryonic camera-type eye development (GO:0031077) | > 100 | 0.01 |
Negative regulation of neuroblast proliferation (GO:0007406) | 99.01 | 0.01 |
Positive regulation of activin receptor signaling pathway (GO:0032927) | 99.01 | 0.01 |
Positive regulation of T-helper 17 cell differentiation (GO:2000321) | 99.01 | 0.01 |
Pyrimidine dimer repair (GO:0006290) | 88.01 | 0.01 |
Post-embryonic animal organ morphogenesis (GO:0048563) | 88.01 | 0.01 |
Positive regulation of T-helper 17 type immune response (GO:2000318) | 79.21 | 0.01 |